Turon Medtech

Turon Medtech has contributed to the development of stereotactic breast biopsy for four decades. Since introducing Cytoguide, the world’s first automated positioning tool for breast biopsy, the company has focused on advancing solutions for precise and efficient procedures. With a dedicated focus on stereotactic breast biopsy, Cytoguide has been integrated into more than 15 mammography models and adopted by several major manufacturers. These integrations reflect an approach built on engineering expertise, clinical understanding, and close collaboration with users and partners. Turon Medtech is characterized by long term thinking, experience, and flexibility, combined with a strong commitment to customer driven and efficient development. High service standards, fast delivery, and close cooperation with both customers and suppliers are central to how we work. Our in house capabilities in R&D, manufacturing, service, and regulatory compliance support the entire product lifecycle. Operations follow a quality management system aligned with ISO 13485 and MDR requirements, emphasizing reliable delivery, responsive support, and practical adaptation to customer needs. Through continuous development, Turon Medtech aims to help shape safer, more efficient, and innovative healthcare, with current concept work focused on improving safety and workflow across the entire pathway from screening to biopsy while exploring advanced technologies to support progress in breast health diagnostics.